Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 10/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23628312 | 0.86 | P2RX7 (0.38) | PDK2P2RX7NPC1LMNAGAA | |
| SCHEMBL23331967 | 0.84 | PDK2 (0.41) | PDK2P2RX7NPC1LMNAGAA | |
| SCHEMBL24272563 | 0.80 | PDK2 (0.33) | PDK2 | |
| SCHEMBL22797175 | 0.79 | PDK2 (0.44) | PDK2P2RX7NPC1LMNAGAA | |
| SCHEMBL24627108 | 0.79 | PDK2 (0.44) | PDK2P2RX7NPC1LMNAGAA | |
| SCHEMBL24728929 | 0.79 | PDK2 (0.44) | PDK2P2RX7NPC1LMNAGAA | |
| SCHEMBL24627119 | 0.79 | P2RX7 (0.31) | P2RX7 | |
| SCHEMBL24626693 | 0.79 | PDK2 (0.41) | PDK2P2RX7 | |
| SCHEMBL24272471 | 0.79 | PDK2 (0.44) | PDK2P2RX7 | |
| SCHEMBL24627110 | 0.77 | P2RX7 (0.38) | PDK2P2RX7NPC1LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11827615-B2 | Nitrogen-containing compound, electronic element and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-11-28 | — | — | US | disclosed |
| US-11827615-B2 | Nitrogen-containing compound, electronic element and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-11-28 | — | — | US | disclosed |
| US-20220223800-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
| US-20220081408-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE | SHAANXI LTMS OPTOELECTRONICS MATERIAL CO. LTD. (CN) | 2022-03-17 | — | — | US | disclosed |
| WO-2021135456-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC DEVICE | 陕西莱特光电材料股份有限公司 | 2021-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11827615-B2 | Nitrogen-containing compound, electronic element and electronic device | NOS1, PRMT1, MNS1 | PDK2 2866/4885P2RX7 2665/4885NPC1 2408/4885 |
| US-20220081408-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE | NOS1, PRMT1, MNS1 | PDK2 2866/4885P2RX7 2665/4885NPC1 2408/4885 |
| US-20220223800-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT, AND ELECTRONIC DEVICE | OCIAD2, EMC2, OCIAD1 | PDK2 1517/4885P2RX7 2567/4885NPC1 885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.